4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-25-033020
Chief Financial Officer sold 57,765 shares at an average $101.78 ($5,879,089)
- Chief Financial Officer acquired 47,889 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bonstein Sara · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-23 | Exercise or conversion : show line 1 in the form 10b5-1 | +35,253 | $18.95 | $668,044 | 138,665 | D |
| 2025-06-23 | Exercise or conversion : show line 2 in the form 10b5-1 | +12,636 | $19.74 | $249,435 | 151,301 | D |
| 2025-06-23 | Sale : show line 3 in the form 10b5-1 | −49,104 | $101.71 | $4,994,368 | 102,197 | D |
| 2025-06-23 | Sale : show line 4 in the form 10b5-1 | −8,661 | $102.15 | $884,721 | 93,536 | D |
| Open-market sales · 57,765 sh · avg $101.78 · $5,879,089 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-23 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | −35,253 | 99,007 | D |
| 2025-06-23 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) | −12,636 | 25,124 | D |
Loading xslF345X05/wk-form4_1750882708.xml…